Key result
In situ RITA bypass via the transverse sinus demonstrated a 6-year cumulative patency rate of 89.3%, which was not significantly different from the 94.5% patency rate of LITA grafts.
Why the study?
Does in situ RITA bypass via the transverse sinus provide comparable long-term patency to LITA grafts in patients undergoing coronary revascularization?
Cohort (n=115)
Does in situ RITA bypass via the transverse sinus provide comparable long-term patency to LITA grafts in patients undergoing coronary revascularization?
In situ RITA bypass via the transverse sinus demonstrates good long-term patency comparable to LITA grafts, supporting its continued use for revascularization.
Answers are grounded in this paper and cite their sources.
Supports in situ RITA via transverse sinus for comparable patency; leaves open randomized confirmation of long-term equivalence.
BACKGROUND: Although concern regarding patency and possible compromise of graft blood flow by routing the right internal thoracic artery (RITA) through the transverse sinus has been raised, little is known about long-term patency. METHODS AND RESULTS: To evaluate long-term patency of in situ RITA bypass via the transverse sinus, our first 115 patients (94 men, 21 women; mean age, 62.5 years; range, 13 to 77 years) who were alive in 1998 were enrolled for angiographic study. Only good-caliber grafts with no occlusion, string sign, or significant stenosis were considered patent. Early postoperative angiography had been performed 2 to 3 weeks after surgery in 114 patients. The early patency rates were 97.1% for RITA and 95.4% for left internal thoracic artery (LITA) grafts. Of 109 long-term survivors, 73 (67.0%) consented to have late angiographic restudy at a mean of 59 months (range, 9 to 93 months); 89.9% of RITA and 92.3% of LITA grafts were patent. Cumulative patency rates (actuarial curves) at 6 years were 89.3% (95% CI, 85% to 94%) for RITA and 94.5% (95% CI, 92% to 97%) for LITA, the differences not reaching statistical significance (multivariate Cox analysis). CONCLUSIONS: Our study demonstrated good long-term patency of in situ RITA bypass grafting via the transverse sinus for revascularization of the circumflex and diagonal arteries and supports its continued use.
No takes yet. Share an insight, caveat, or question.
Ura et al. (1998) conducted a cohort in Coronary artery disease requiring revascularization (n=115). In situ RITA bypass via the transverse sinus vs. Left internal thoracic artery (LITA) grafts was evaluated on Cumulative patency rate at 6 years. In situ RITA bypass via the transverse sinus demonstrated a 6-year cumulative patency rate of 89.3%, which was not significantly different from the 94.5% patency rate of LITA grafts.
Synapse has enriched 10 related papers. Consider them for comparative context: